State of TMJ Bioengineering: Working Together Toward Improving Clinical Outcomes.
The 6th temporomandibular joint (TMJ) Bioengineering Conference (TMJBC) was held June 14-15, 2018, in Redondo Beach, California, 12 years after the first TMJBC. Speakers gave 30 presentations, and came from the United States, Europe, Asia, and Australia. The goal of the conference has remained to foster a continuing forum for bioengineers, scientists, and surgeons and veterinarians to advance technology related to TMJ disorders. These collective multidisciplinary interactions over the past decade have made large strides in moving the field of TMJ research forward. Over the past 12 years, in vivo approaches for tissue engineering have emerged, along with a wide variety of degeneration models, as well as with models occurring in nature. Furthermore, biomechanical tools have become more sensitive and new biologic interventions for disease are being developed. Clinical directives have evolved for specific diagnoses, along with patient-specific biological and immunological responses to TMJ replacement devices alloplastic and/or bioengineered devices. The 6th TMJBC heralded many opportunities for funding agencies to advance the field: 1) initiatives on TMJ that go beyond pain research, 2) more training grants focused on graduate students and fellows, 3) partnership funding with government agencies to translate TMJ solutions, and 4) the recruitment of a critical mass of TMJ experts to participate on grant review panels. The TMJ research community continues to grow and has become a pillar of dental and craniofacial research, and together we share the unified vision to ultimately improve diagnoses and treatment outcomes in patients affected by TMJ disorders.